CHARLES SCHWAB INVESTMENT MANAGEMENT INC - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 85 filers reported holding OVID THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 6.38 and the average weighting 0.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$652,938
+22.4%
170,036
+4.5%
0.00%
Q2 2023$533,482
+480.2%
162,647
+356.4%
0.00%
Q1 2023$91,946
+154.1%
35,638
+83.2%
0.00%
Q4 2022$36,181
+0.5%
19,4520.0%0.00%
Q3 2022$36,000
-14.3%
19,4520.0%0.00%
Q2 2022$42,000
-32.3%
19,4520.0%0.00%
Q1 2022$62,000
-1.6%
19,4520.0%0.00%
Q4 2021$63,000
-4.5%
19,4520.0%0.00%
Q3 2021$66,000
-14.3%
19,4520.0%0.00%
Q2 2021$77,000
-83.9%
19,452
-83.6%
0.00%
Q1 2021$478,000
+91.2%
118,778
+10.1%
0.00%
Q4 2020$250,000
-55.4%
107,882
+10.7%
0.00%
Q3 2020$560,000
-24.7%
97,439
-3.4%
0.00%
Q2 2020$744,000
+1228.6%
100,851
+442.9%
0.00%
Q1 2020$56,000
-28.2%
18,5780.0%0.00%
Q4 2019$78,000
-42.6%
18,578
-74.6%
0.00%
Q2 2019$136,000
-24.0%
73,229
-27.2%
0.00%
Q1 2019$179,000
+26.1%
100,598
+72.0%
0.00%
Q4 2018$142,000
-58.1%
58,471
-2.0%
0.00%
Q3 2018$339,000
+24.2%
59,687
+70.8%
0.00%
Q2 2018$273,000
+12.3%
34,940
+1.9%
0.00%
Q1 2018$243,000
+19.7%
34,295
+67.2%
0.00%
Q4 2017$203,000
+62.4%
20,510
+41.4%
0.00%
Q3 2017$125,000
-18.3%
14,5000.0%0.00%
Q2 2017$153,00014,5000.00%
Other shareholders
OVID THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 4,006,185$12,860,0005.90%
GLOBEFLEX CAPITAL L P 2,794,834$8,972,0000.92%
BVF INC/IL 6,631,051$21,286,0000.77%
EcoR1 Capital, LLC 6,082,200$19,524,0000.62%
CHI Advisors LLC 400,000$1,284,0000.43%
Ikarian Capital, LLC 705,082$2,264,0000.34%
Artal Group S.A. 2,500,000$8,025,0000.22%
DCF Advisers, LLC 141,701$455,0000.18%
PLATINUM INVESTMENT MANAGEMENT LTD 766,901$2,462,0000.07%
ACADIAN ASSET MANAGEMENT LLC 2,040,084$6,543,0000.02%
View complete list of OVID THERAPEUTICS INC shareholders